DXC vs TECH
DXC Technology Co (DXC) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
DXC Technology Co (DXC) is a information technology services company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported DXC revenue for 2025-03-31 was $12.87B. Net income was $396.0M. Revenue was down 5.8% from 2024-03-31 to 2025-03-31. DXC currently screens at market cap $2.92B and trailing P/E 7.6.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
DXC currently screens at market cap $2.92B and trailing P/E 7.6. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the DXC and TECH stock pages for the full models.
Not investment advice.